Yong Jiang

Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study

Yuankai Shi, Gongyan Chen, Xiang Wang et al. · The Lancet Respiratory Medicine · 2022 · 230 citations

Medicine, Oncology, Pharmacology +13

Astrocytic LRP1 enables mitochondria transfer to neurons and mitigates brain ischemic stroke by suppressing ARF1 lactylation

Jian Zhou, Lifang Zhang, Jianhua Peng et al. · Cell Metabolism · 2024 · 224 citations

Medicine, Neurobiology, Neuroscience +13

Sex-specific reference intervals of hematologic and biochemical analytes in Sprague-Dawley rats using the nonparametric rank percentile method

Qili He, Guoming Su, Keliang Liu et al. · PLoS ONE · 2017 · 152 citations · Full text

Pharmacy, Hematology, Toxicology +13

Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy

Li‐Xi Liao, Xiaomin Song, Lichao Wang et al. · Proceedings of the National Academy of Sciences · 2017 · 150 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

8-C N-ethyl-2-pyrrolidinone substituted flavan-3-ols as the marker compounds of Chinese dark teas formed in the post-fermentation process provide significant antioxidative activity

Weinan Wang, Liang Zhang, Shu Wang et al. · Food Chemistry · 2013 · 128 citations

Agriculture, Biochemistry, Food Science +10